Recombinant insulin glargine (Chongqing Fujin Biological Medicine)
重组甘精胰岛素（重庆富进生物医药）
Report date: 2025/04/20 20:00:03
Base Information
Drug NameRecombinant insulin glargine (Chongqing Fujin Biological Medicine)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesChongqing Fujin Biological Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesChongqing Fujin Biological Medicine Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A